Aoti Inc., of Oceanside, Calif., entered a strategic relationship with Nanning Xinzizhu Trading Co. Ltd. for distribution of Aoti's topical wound oxygen (TWO2) therapy product in China. The multiyear agreement includes a sales expectation requirement that is said to amount to just less than $18 million. Aoti's TWO2 therapy is for diabetic, venous and pressure ulcer treatment.
The Applied Medical Device Institute at Grand Valley State University in Allendale Township, Mich., has won a $500,000 grant for research into additive manufacturing for medical devices. The grant was awarded by the Grand Rapids Smartzone, and the institute will use a 3D printer made by Carbon Inc. in a collaboration with Medisurge.
Invitrocue Ltd., of New South Wales, Australia, signed a lab agreement in Germany to market its Onco-PDO cancer screening service. The lab will serve as a reference lab for the test when performed at any location in Europe. The lab will be located in Berlin, the company said.